MCID: MCC002
MIFTS: 49

Mucocutaneous Leishmaniasis

Categories: Infectious diseases

Aliases & Classifications for Mucocutaneous Leishmaniasis

MalaCards integrated aliases for Mucocutaneous Leishmaniasis:

Name: Mucocutaneous Leishmaniasis 12 15 73
American Cutaneous Leishmaniasis 12 73
Mucocutaneous Leishmaniasis, American 12
American Mucocutaneous Leishmaniasis 12
Cutaneous Leishmaniasis, American 12
New World Cutaneous Leishmaniasis 12
Leishmaniasis, Mucocutaneous 44

Classifications:



External Ids:

Disease Ontology 12 DOID:9155
ICD10 33 B55.2
ICD9CM 35 085.5
MeSH 44 D007897
SNOMED-CT 68 39625001

Summaries for Mucocutaneous Leishmaniasis

Disease Ontology : 12 A leishmaniasis that involves a chronic inflammatory process involving the nasal, pharyngeal, and laryngeal mucosa, which can lead to extensive tissue destruction, caused by protozoan parasites belonging to the genus Leishmania. The infection is characterized by granulomatous lesion which can destroy upper respiratory tract mucosa.

MalaCards based summary : Mucocutaneous Leishmaniasis, also known as american cutaneous leishmaniasis, is related to leishmaniasis and visceral leishmaniasis. An important gene associated with Mucocutaneous Leishmaniasis is TNF (Tumor Necrosis Factor), and among its related pathways/superpathways are Akt Signaling and Toll-like Receptor Signaling Pathway. The drugs Meglumine antimoniate and Anti-Infective Agents have been mentioned in the context of this disorder. Affiliated tissues include t cells, testes and skin, and related phenotypes are cardiovascular system and hematopoietic system

Related Diseases for Mucocutaneous Leishmaniasis

Diseases related to Mucocutaneous Leishmaniasis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 159)
# Related Disease Score Top Affiliating Genes
1 leishmaniasis 31.3 CCR5 IL10 TLR9 TNF
2 visceral leishmaniasis 30.3 IL10 TLR9 TNF
3 paracoccidioidomycosis 30.3 IL10 TNF
4 cutaneous leishmaniasis 30.3 IL10 TLR9 TNF
5 lepromatous leprosy 30.1 IL10 TNF
6 pulmonary tuberculosis 30.0 IL10 TLR9 TNF
7 human immunodeficiency virus infectious disease 29.9 CCR5 IL10 TLR9 TNF
8 acquired immunodeficiency syndrome 29.9 CCR5 IL10 TNF
9 chagas disease 29.9 CCR5 IL10 TNF
10 viral infectious disease 29.4 CCR5 IL10 TLR3 TLR9 TNF
11 kala-azar 1 10.9
12 adult dermatomyositis 10.2 TLR9 TNF
13 central nervous system vasculitis 10.2 TLR9 TNF
14 hemorrhagic fever 10.2 IL10 TNF
15 punctate inner choroidopathy 10.2 IL10 TNF
16 tropical endomyocardial fibrosis 10.2 IL10 TNF
17 endomyocardial fibrosis 10.2 IL10 TNF
18 hypersensitivity reaction type iii disease 10.2 TLR9 TNF
19 lichen disease 10.2 TLR9 TNF
20 microscopic polyangiitis 10.2 IL10 TNF
21 multifocal choroiditis 10.2 IL10 TNF
22 choroiditis 10.2 IL10 TNF
23 tungiasis 10.2 IL10 TNF
24 transient hypogammaglobulinemia 10.2 IL10 TNF
25 cow milk allergy 10.2 IL10 TNF
26 trichuriasis 10.2 IL10 TNF
27 idiopathic achalasia 10.2 IL10 TNF
28 chronic graft versus host disease 10.2 IL10 TNF
29 middle ear disease 10.2 TLR9 TNF
30 clonorchiasis 10.2 IL10 TNF
31 trachoma 10.2 IL10 TNF
32 autoimmune gastritis 10.2 IL10 TNF
33 eye lymphoma 10.2 IL10 TLR9
34 intermediate uveitis 10.2 IL10 TNF
35 transverse myelitis 10.2 IL10 TNF
36 post-transplant lymphoproliferative disease 10.2 IL10 TNF
37 primary systemic mycosis 10.2 IL10 TNF
38 hypersensitivity reaction type iv disease 10.2 TLR9 TNF
39 perinatal necrotizing enterocolitis 10.2 TLR9 TNF
40 mycoplasma pneumoniae pneumonia 10.2 IL10 TNF
41 filarial elephantiasis 10.2 IL10 TLR9
42 multidrug-resistant tuberculosis 10.2 IL10 TNF
43 poliomyelitis 10.2 IL10 TNF
44 eales disease 10.2 IL10 TNF
45 spotted fever 10.2 IL10 TNF
46 hematopoietic stem cell transplantation 10.2 IL10 TNF
47 aseptic meningitis 10.2 IL10 TNF
48 scrub typhus 10.2 IL10 TNF
49 panuveitis 10.2 IL10 TNF
50 exanthem 10.2 TLR9 TNF

Graphical network of the top 20 diseases related to Mucocutaneous Leishmaniasis:



Diseases related to Mucocutaneous Leishmaniasis

Symptoms & Phenotypes for Mucocutaneous Leishmaniasis

MGI Mouse Phenotypes related to Mucocutaneous Leishmaniasis:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 9.95 CCR5 FLI1 IL10 NID1 SCYL1 TLR3
2 hematopoietic system MP:0005397 9.91 CCR5 FLI1 IL10 SCYL1 TLR3 TLR9
3 immune system MP:0005387 9.87 CCR5 FLI1 IL10 SCYL1 TLR3 TLR9
4 muscle MP:0005369 9.8 CCR5 FLI1 IL10 NID1 SCYL1 TLR3
5 neoplasm MP:0002006 9.55 CCR5 FLI1 IL10 TLR3 TNF
6 nervous system MP:0003631 9.5 CCR5 FLI1 IL10 NID1 SCYL1 TLR3
7 vision/eye MP:0005391 9.02 CCR5 IL10 NID1 SCYL1 TNF

Drugs & Therapeutics for Mucocutaneous Leishmaniasis

Drugs for Mucocutaneous Leishmaniasis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 25)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Meglumine antimoniate Experimental, Investigational Phase 2, Phase 3 133-51-7
2 Anti-Infective Agents Phase 2, Phase 3,Phase 1
3 Antiparasitic Agents Phase 2, Phase 3,Phase 1
4 Antiprotozoal Agents Phase 2, Phase 3,Phase 1
5
Miconazole Approved, Investigational, Vet_approved Phase 2,Phase 1 22916-47-8 4189
6
Miltefosine Approved, Investigational Phase 2,Phase 1 58066-85-6 3600
7
Coal tar Approved Phase 2 8007-45-2
8
Amphotericin B Approved, Investigational Phase 1, Phase 2,Phase 2 1397-89-3 5280965 14956
9
Pentoxifylline Approved, Investigational Phase 2 6493-05-6 4740
10 Antifungal Agents Phase 2,Phase 1
11 Liposomal amphotericin B Phase 1, Phase 2,Phase 2
12 Antimony Sodium Gluconate Phase 1, Phase 2,Phase 2
13 Anthelmintics Phase 1, Phase 2,Phase 2
14 Vasodilator Agents Phase 2
15 Radiation-Protective Agents Phase 2
16 Phosphodiesterase Inhibitors Phase 2
17 Antioxidants Phase 2
18 Protective Agents Phase 2
19 Free Radical Scavengers Phase 2
20 Platelet Aggregation Inhibitors Phase 2
21 Immunologic Factors Phase 1
22 Vaccines Phase 1
23
Cortisone acetate Approved, Investigational 1950-04-4, 50-04-4 5745
24
Cortisone Experimental 53-06-5 222786
25 Anti-Inflammatory Agents

Interventional clinical trials:

(show all 15)
# Name Status NCT ID Phase Drugs
1 Low Antimonial Dosage in American Mucosal Leishmaniasis Recruiting NCT01301937 Phase 2, Phase 3 Meglumine antimoniate
2 Miltefosine to Treat Mucocutaneous Leishmaniasis Completed NCT01050907 Phase 2 miltefosine
3 Clinical Trial of Miltefosine to Treat Mucosal Leishmaniasis Completed NCT01377974 Phase 2 Miltefosine;Standard Treatment Meglumine antimoniate
4 Miltefosine for Mucosal Leishmaniasis Completed NCT00373776 Phase 1, Phase 2 miltefosine 2.5 mg/kg/day for 28 days
5 Miltefosine (Long Course) for Bolivian Mucosal Leishmaniasis Completed NCT00373568 Phase 1, Phase 2 miltefosine: 2.5 mg/kg/day for 42 days
6 Use of Sodium Stibogluconate as a Treatment for Leishmaniasis Completed NCT00657618 Phase 1, Phase 2 Sodium Stibogluconate (SSG)
7 Sodium Stibogluconate Treatment of Leishmaniasis Completed NCT00662012 Phase 2 Sodium Stibogluconate (SSG)
8 Miltefosine to Treat Cutaneous Leishmaniasis in Bolivia Completed NCT00233545 Phase 2 miltefosine;antimony
9 The Association of Miltefosine and Pentoxifylline to Treat Mucosal Leishmaniasis: A Clinical Trial in Brazil Recruiting NCT02530697 Phase 2 Meglumine antimoniate;Miltefosine;Pentoxifylline
10 Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Mucosal Leishmaniasis Completed NCT00111514 Phase 1
11 Dedicated QT Study in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis Recruiting NCT02429518 Miltefosine
12 Spermiogram Assessment in Bolivian Patients Taking Impavido® (Miltefosine) for Mucocutaneous Leishmaniasis Recruiting NCT02431429 Miltefosine
13 Cortisone and QTc-Interval Recruiting NCT03082339
14 Diagnosis and Treatment of Leishmanial Infections Recruiting NCT00344188
15 Compassionate Use of Sodium Stibogluconate (Pentostam) for Cutaneous and Mucocutaneous New World Leishmaniasis Available NCT00508963 sodium stibogluconate (Pentostam)

Search NIH Clinical Center for Mucocutaneous Leishmaniasis

Cochrane evidence based reviews: leishmaniasis, mucocutaneous

Genetic Tests for Mucocutaneous Leishmaniasis

Anatomical Context for Mucocutaneous Leishmaniasis

MalaCards organs/tissues related to Mucocutaneous Leishmaniasis:

41
T Cells, Testes, Skin, Bone, Heart, Lymph Node, Eye

Publications for Mucocutaneous Leishmaniasis

Articles related to Mucocutaneous Leishmaniasis:

(show top 50) (show all 383)
# Title Authors Year
1
Gene expression profile of cytokines produced in biopsies from patients with American cutaneous leishmaniasis. ( 30273562 )
2019
2
Rare Tongue Compromising of Mucocutaneous Leishmaniasis by Leishmania Subgenus Viannia. ( 29519666 )
2018
3
Regulatory T-Cell Dynamics in Cutaneous and Mucocutaneous Leishmaniasis due to<i>Leishmania braziliensis</i>. ( 29405108 )
2018
4
An Atypical Presentation of Disseminated Mucocutaneous Leishmaniasis Caused by <i>Leishmania major</i> In Iran. ( 29963099 )
2018
5
Cheilitis: An unusual presentation of Mucocutaneous Leishmaniasis. ( 29988622 )
2018
6
Combination of flow cytometry and qPCR to study the immune response of american cutaneous leishmaniasis patients. ( 30076983 )
2018
7
Sand fly fauna (Diptera: Psychodidae) from Serra da Mocidade Nacional Park: report of vectors and putative vectors of American cutaneous leishmaniasis and new records for the state of Roraima, Brazil. ( 30486063 )
2018
8
Ecological aspects of Phlebotomines (Diptera: Psychodidae) and the transmission of American cutaneous leishmaniasis agents in an Amazonian/ Guianan bordering area. ( 30497528 )
2018
9
American cutaneous leishmaniasis in a northeast Brazilian city: clinical and epidemiological features. ( 30517540 )
2018
10
Molecular typing reveals the co-existence of two transmission cycles of American cutaneous leishmaniasis in the Andean Region of Venezuela with Lutzomyia migonei as the vector. ( 30540021 )
2018
11
American cutaneous leishmaniasis triggered by electrocoagulation. ( 29513830 )
2018
12
Environmental suitability for Lutzomyia (Nyssomyia) whitmani (Diptera: Psychodidae: Phlebotominae) and the occurrence of American cutaneous leishmaniasis in Brazil. ( 29514680 )
2018
13
Toll-like receptors 2, 4, and 9 expressions over the entire clinical and immunopathological spectrum of American cutaneous leishmaniasis due to Leishmania(V.) braziliensis and Leishmania (L.) amazonensis. ( 29543867 )
2018
14
Leprosy and American cutaneous leishmaniasis coinfection. ( 29641713 )
2018
15
Urban American cutaneous leishmaniasis. ( 29641726 )
2018
16
Formulation and Characterization of a Self-Emulsifying Drug Delivery system (SEDDS) of Curcumin for the Topical Application in Cutaneous and Mucocutaneous Leishmaniasis. ( 30360717 )
2018
17
Differentiation of mucosal lesions in mucocutaneous leishmaniasis and paracoccidioidomycosis. ( 30475920 )
2018
18
Mucocutaneous Leishmaniasis in Immunocompromised Patients: Report of 4 Cases in Spain. ( 29100620 )
2017
19
Synthetic peptides derived from ribosomal proteins of Leishmania spp. in mucocutaneous leishmaniasis: Diagnostic usefulness. ( 28758598 )
2017
20
Deforming Mucocutaneous Leishmaniasis of the Nose. ( 28538073 )
2017
21
Cost-effectiveness of liposomal amphotericin B in hospitalised patients with mucocutaneous leishmaniasis. ( 29078022 )
2017
22
Phlebotomine Sand Fly Composition (Diptera: Psychodidae) and Putative Vectors of American Cutaneous Leishmaniasis in Porto Velho Municipality, Western Amazon, Brazil. ( 28399264 )
2017
23
Epidemiological aspects of American cutaneous leishmaniasis (ACL) in an endemic area of forest extractivist culture in western Brazilian Amazonia. ( 28423087 )
2017
24
Natural Leishmania (Viannia) infections of phlebotomines (Diptera: Psychodidae) indicate classical and alternative transmission cycles of American cutaneous leishmaniasis in the Guiana Shield, Brazil. ( 28508745 )
2017
25
Low versus high dose of antimony for American cutaneous leishmaniasis: A randomized controlled blind non-inferiority trial in Rio de Janeiro, Brazil. ( 28558061 )
2017
26
Spatial and temporal distribution of American cutaneous leishmaniasis in Acre state, Brazil. ( 28587683 )
2017
27
A secondary wave of neutrophil infiltration causes necrosis and ulceration in lesions of experimental American cutaneous leishmaniasis. ( 28591228 )
2017
28
Attractiveness of black and white modified Shannon traps to phlebotomine sandflies (Diptera, Psychodidae) in the Brazilian Amazon Basin, an area of intense transmission of American cutaneous leishmaniasis. ( 28593838 )
2017
29
American cutaneous leishmaniasis in infancy and childhood. ( 28741648 )
2017
30
Erratum to: Thermotherapy. An alternative for the treatment of American cutaneous leishmaniasis. ( 28863783 )
2017
31
Reappraisal of Leishmanin Skin Test (LST) in the management of American Cutaneous Leishmaniasis: A retrospective analysis from a reference center in Argentina. ( 28981507 )
2017
32
American cutaneous leishmaniasis: In situ immune response of patients with recent and late lesions. ( 28239875 )
2017
33
Unusual presentation of mucocutaneous leishmaniasis in HIV-infected patient. ( 27890957 )
2016
34
Mucocutaneous leishmaniasis. ( 26994882 )
2016
35
Mucocutaneous leishmaniasis with marked facial disfigurement. ( 27643545 )
2016
36
Asymptomatic infection with American cutaneous leishmaniasis: epidemiological and immunological studies. ( 27759762 )
2016
37
The Cure Rate after Placebo or No Therapy in American Cutaneous Leishmaniasis: A Systematic Review and Meta-Analysis. ( 26894430 )
2016
38
AMERICAN CUTANEOUS LEISHMANIASIS WITH UNUSUAL CLINICAL PRESENTATION AND RESPONSE TO TREATMENT. ( 27007563 )
2016
39
Effector memory CD4(+) T cells differentially express activation associated molecules depending on the duration of American cutaneous leishmaniasis lesions. ( 27059407 )
2016
40
Natural Leishmania (Viannia) spp. infections in phlebotomine sand flies (Diptera: Psychodidae) from the Brazilian Amazon region reveal new putative transmission cycles of American cutaneous leishmaniasis. ( 27235194 )
2016
41
Clinical and Parasitological Features of Patients with American Cutaneous Leishmaniasis that Did Not Respond to Treatment with Meglumine Antimoniate. ( 27243811 )
2016
42
Phlebotomine sandfly (Diptera: Psychodidae) diversity and their Leishmania DNA in a hot spot of American Cutaneous Leishmaniasis human cases along the Brazilian border with Peru and Bolivia. ( 27304023 )
2016
43
Macroecological patterns of American Cutaneous Leishmaniasis transmission across the health areas of Panamá (1980-2012). ( 29988197 )
2016
44
Mucocutaneous leishmaniasis of the nose: a case report. ( 26513953 )
2015
45
Immune response to Leishmania antigens in an AIDS patient with mucocutaneous leishmaniasis as a manifestation of immune reconstitution inflammatory syndrome (IRIS): a case report. ( 25645330 )
2015
46
Cutaneous and mucocutaneous leishmaniasis: Differential diagnosis, diagnosis, histopathology, and management. ( 26568336 )
2015
47
Short communication: mucocutaneous leishmaniasis in HIV-related immune reconstitution syndrome. ( 26154873 )
2015
48
Mucocutaneous leishmaniasis in an 11-year-old girl with ataxia telangectasia - case report. ( 25661291 )
2015
49
Polymerase chain reaction-miniexon: a promising diagnostic method for mucocutaneous leishmaniasis. ( 26452681 )
2015
50
Accuracy of mucocutaneous leishmaniasis diagnosis using polymerase chain reaction: systematic literature review and meta-analysis. ( 25830540 )
2015

Variations for Mucocutaneous Leishmaniasis

Expression for Mucocutaneous Leishmaniasis

Search GEO for disease gene expression data for Mucocutaneous Leishmaniasis.

Pathways for Mucocutaneous Leishmaniasis

Pathways related to Mucocutaneous Leishmaniasis according to GeneCards Suite gene sharing:

(show all 16)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
13.07 CCR5 IL10 TLR3 TLR9 TNF
2
Show member pathways
12.69 IL10 TLR3 TLR9 TNF
3
Show member pathways
12.14 CCR5 IL10 TNF
4
Show member pathways
11.95 TLR3 TLR9 TNF
5
Show member pathways
11.93 CCR5 IL10 TNF
6 11.89 IL10 TLR9 TNF
7
Show member pathways
11.85 IL10 TLR9 TNF
8 11.8 TLR3 TLR9 TNF
9 11.54 FLI1 IL10 TLR3 TLR9 TNF
10 11.41 IL10 TLR9 TNF
11
Show member pathways
11.37 IL10 TLR3 TLR9 TNF
12 11.19 CCR5 IL10 TNF
13 11.12 IL10 TLR9 TNF
14 11.09 IL10 TNF
15 10.97 IL10 TNF
16 10.88 IL10 TLR9 TNF

GO Terms for Mucocutaneous Leishmaniasis

Cellular components related to Mucocutaneous Leishmaniasis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 endolysosome membrane GO:0036020 8.62 TLR3 TLR9

Biological processes related to Mucocutaneous Leishmaniasis according to GeneCards Suite gene sharing:

(show all 42)
# Name GO ID Score Top Affiliating Genes
1 immune response GO:0006955 9.94 CCR5 IL10 TLR9 TNF
2 cytokine-mediated signaling pathway GO:0019221 9.86 CCR5 IL10 TNF
3 positive regulation of I-kappaB kinase/NF-kappaB signaling GO:0043123 9.83 TLR3 TLR9 TNF
4 cellular response to lipopolysaccharide GO:0071222 9.83 CCR5 IL10 TNF
5 positive regulation of NF-kappaB transcription factor activity GO:0051092 9.81 TLR3 TLR9 TNF
6 defense response GO:0006952 9.8 CCR5 TLR3 TNF
7 defense response to bacterium GO:0042742 9.78 IL10 TLR3 TLR9 TNF
8 positive regulation of JNK cascade GO:0046330 9.73 TLR3 TLR9 TNF
9 positive regulation of inflammatory response GO:0050729 9.71 TLR3 TLR9 TNF
10 extrinsic apoptotic signaling pathway GO:0097191 9.68 TLR3 TNF
11 positive regulation of JUN kinase activity GO:0043507 9.68 TLR9 TNF
12 toll-like receptor signaling pathway GO:0002224 9.68 TLR3 TLR9
13 negative regulation of mitotic cell cycle GO:0045930 9.68 IL10 TNF
14 positive regulation of cytokine production GO:0001819 9.67 TLR3 TNF
15 positive regulation of cytokine secretion GO:0050715 9.67 IL10 TNF
16 regulation of synapse organization GO:0050807 9.67 IL10 TNF
17 I-kappaB kinase/NF-kappaB signaling GO:0007249 9.67 TLR3 TLR9 TNF
18 positive regulation of interferon-beta production GO:0032728 9.66 TLR3 TLR9
19 positive regulation of interleukin-12 production GO:0032735 9.66 TLR3 TLR9
20 microglial cell activation GO:0001774 9.65 TLR3 TNF
21 positive regulation of interleukin-6 production GO:0032755 9.63 TLR3 TLR9 TNF
22 negative regulation of growth of symbiont in host GO:0044130 9.62 IL10 TNF
23 positive regulation of heterotypic cell-cell adhesion GO:0034116 9.62 IL10 TNF
24 positive regulation of interferon-gamma biosynthetic process GO:0045078 9.61 TLR3 TLR9
25 I-kappaB phosphorylation GO:0007252 9.61 TLR3 TLR9
26 response to molecule of bacterial origin GO:0002237 9.6 IL10 TLR9
27 positive regulation of interleukin-8 biosynthetic process GO:0045416 9.59 TLR9 TNF
28 endothelial cell apoptotic process GO:0072577 9.58 IL10 TNF
29 positive regulation of chemokine biosynthetic process GO:0045080 9.58 TLR3 TNF
30 positive regulation of interferon-beta biosynthetic process GO:0045359 9.57 TLR3 TLR9
31 negative regulation of interleukin-8 production GO:0032717 9.55 IL10 TLR9
32 positive regulation of NIK/NF-kappaB signaling GO:1901224 9.54 TLR3 TLR9 TNF
33 necroptotic signaling pathway GO:0097527 9.52 TLR3 TNF
34 negative regulation of cytokine secretion involved in immune response GO:0002740 9.51 IL10 TNF
35 positive regulation of interferon-alpha biosynthetic process GO:0045356 9.43 TLR3 TLR9
36 negative regulation of interleukin-6 production GO:0032715 9.43 IL10 TLR9 TNF
37 positive regulation of toll-like receptor signaling pathway GO:0034123 9.4 TLR3 TLR9
38 inflammatory response GO:0006954 9.35 CCR5 IL10 TLR3 TLR9 TNF
39 positive regulation of interleukin-8 production GO:0032757 9.33 TLR3 TLR9 TNF
40 receptor biosynthetic process GO:0032800 9.32 IL10 TNF
41 positive regulation of chemokine production GO:0032722 8.8 TLR3 TLR9 TNF
42 positive regulation of transcription by RNA polymerase II GO:0045944 10.04 FLI1 IL10 TLR3 TLR9 TNF

Sources for Mucocutaneous Leishmaniasis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....